Drug
Ibandronic Acid clinical trials
Also written Ibandronate, Boniva and Bonviva.
- studies test it
- 63
- open now
- 3
- in phase 3
- 24
- first study started
- 2002
Keep track of what changes. Save the Ibandronic Acid studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Other names
Combined with it in one product
Studies by the year they started
61 studies that test it; most in 2006 (17)
| Year | Studies |
|---|---|
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 8 |
| 2005 | 8 |
| 2006 | 17 |
| 2007 | 11 |
| 2008 | 4 |
| 2010 | 1 |
| 2011 | 3 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2023 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 9
- Phase 3
- 24
- Phase 4
- 28
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
- Pain
- 1
Who runs them
Industry 39 · Other 24
Hoffmann-La Roche (32) · GlaxoSmithKline (3) · SWOG Cancer Research Network (2) · Columbia University (1) · Yeouido St. Mary's Hospital (1) · Organon and Co (1) · Azienda Ospedaliero-Universitaria Careggi (1) · M.D. Anderson Cancer Center (1)
Often tested with
Tested in the same studies.
Calcium (3) · Vitamin D (3) · Alendronate (3) · Zoledronic Acid (2) · Cholecalciferol (1) · Risedronic Acid (1) · Capecitabine (1) · Parathyroid Hormone (1)
Studies
Open first, then newest update. How each study uses Ibandronic Acid is read from its arms, and is right about nine times in ten.
Testing it · 63
- The Comparison of Ibandronate and Zoledronic Acid After Denosumab DiscontinuationRecruitingPhase 4National Taiwan University HospitalNCT07406685Written as Ibandronate IV
- Efficacy and Safety of Oral Ibandronate in Patients of Liver Cirrhosis With Hepatic Osteodystrophy.Not yet recruitingNot applicableInstitute of Liver and Biliary Sciences, IndiaNCT06022237Written as Ibandronate
- Efficacy of Oral Ibandronate in OsteoporosisRecruitingPhase 2Shinshu UniversityNCT03186131Written as Ibandronate
- Coral Calcium's Effect on Bone Density in Postmenopausal Women With and Without IbandronateCompletedPhase 2Columbia UniversityNCT04321837Written as Ibandronate
- Use of Ibandronate in Diabetic PatientsCompletedNot applicableYeouido St. Mary's HospitalNCT05266261Written as Ibandronate Oral Tablet
- Study of Investigational Drug in Osteoporosis (MK-0217-908)CompletedPhase 3Organon and CoNCT00092053Written as ibandronate
- S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.CompletedPhase 3SWOG Cancer Research NetworkNCT00127205Written as ibandronate sodium
- Study of Oral Bisphosphonate for Osteopenic Women Treated With Adjuvant Aromatase InhibitorsCompletedPhase 2Azienda Ospedaliero-Universitaria CareggiNCT02616744Written as Ibandronic acid
- Study Of The Efficacy And Security Of Ibandronate For Osteoporosis Treatment In A HIV-Infected Patients CohortWithdrawnPhase 4Germans Trias i Pujol HospitalNCT00662077Written as Ibandronate
- Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) PatientsCompletedPhase 3M.D. Anderson Cancer CenterNCT00824993Written as Ibandronate
- Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal OsteoporosisCompletedPhase 4GlaxoSmithKlineNCT00405392Written as Ibandronate (SB743830HD)
- MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal OsteoporosisCompletedPhase 3Hoffmann-La RocheNCT00048061Written as Ibandronate [Bonviva/Boniva]
- Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential EffectsCompletedPhase 2Sheffield Teaching Hospitals NHS Foundation TrustNCT00666627Written as Ibandronate
- A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone DiseaseTerminatedPhase 3Hoffmann-La RocheNCT00099203Written as ibandronate [Bondronat]
- A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe PainTerminatedPhase 3Hoffmann-La RocheNCT00099177Written as ibandronate [Bondronat]
- A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease.WithdrawnPhase 2Hoffmann-La RocheNCT00478270Written as ibandronate [Bondronat]
- A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With BonvivaCompletedPhase 4Hoffmann-La RocheNCT00081653Written as ibandronate [Bonviva/Boniva]
- Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly AlendronateCompletedPhase 4GlaxoSmithKlineNCT00327990Written as Ibandronate
- Study Comparing Ibandronate Versus Placebo in Hip OsteonecrosisTerminatedPhase 3Brigitte Jolles, MDNCT02114489Written as ibandronate
- A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia.CompletedPhase 3Hoffmann-La RocheNCT00545207Written as ibandronate [Bonviva/Boniva]
See all 63 studies that test Ibandronic Acid →
As the comparator · 3 — what is tested is compared with Ibandronic Acid
- Bone Turnover Markers and Treatment Efficacy in Postmenopausal OsteoporosisCompletedNot applicableKhyber Medical University PeshawarNCT07242612Written as Alendronate, Ibandronate; Risedronate
- Phase III Clinical Trial of DP-R206 and Bonvia In Postmenopausal Women With OsteoporosisCompletedPhase 3Alvogen KoreaNCT01581320Written as Reference group
- A Study to Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated With Daily or Weekly BisphosphonatesCompletedPhase 3AmgenNCT00936897Written as Ibandronate
Codes
What other systems call Ibandronic Acid · ClinicalTrials.gg INT006753
- MeSH (NLM) D000077557Ibandronic AcidConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) UMD7G2653WIBANDRONIC ACIDConfirmed FDA, NLM, Wikidata
- RxNorm 115265Confirmed FDA, Wikidata
- Wikidata Q166825ibandronic acidConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65874Ibandronic AcidOne source FDA
- DrugBank DB00710One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077557 | Ibandronic Acid | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | UMD7G2653W | IBANDRONIC ACID | Confirmed FDA, NLM, Wikidata |
| RxNorm | 115265 | — | Confirmed FDA, Wikidata |
| Wikidata | Q166825 | ibandronic acid | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65874 | Ibandronic Acid | One source FDA |
| DrugBank | DB00710 | — | One source Wikidata |
Also registered as ibandronate sodium (UNII J12U072QL0 · RxNorm 236916) and ibandronate sodium anhydrous (UNII 23Y0B94E49).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.